Supreme Court Hears Landmark MedImmune Appeal
The high court agreed to hear the case in March, putting the spotlight on a patent dispute over Synagis, a drug designed to prevent dangerous respiratory tract infections that afflict about 125,000 children in the United States each year.
One of 38 cases accepted by the high court for...
Already a subscriber? Click here to login